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The cytolytic T lymphocyte response to the murine 
c ytomegalovir us 
11. Detection of virus replication stage-specific antigens 
by separate populations of in vivo active cytolytic 
T lymphocyte precursors* 
During the acute cytolytic T lymphocyte (CTL) response of mice to  infection with the 
murine cytomegalovirus two independent populations of activated interleukin-recep- 
tive CTL precursors can be demonstrated. One  population is specific for cell mem- 
brane-incorporated viral structural antigens, whereas the second population detects 
an antigen, whose appearance is correlated with the synthesis of viral immediate early 
proteins. Since this new type of antigen is only defined by lymphocyte recognition, it 
is referred to  as the lymphocyte-detected immediate early antigen (LYDIEA). Ex- 
pression of immediate early antigen precedes the production of viral progeny and, 
therefore, it is possible that LYDIEA-specific CTL could serve as indicator cells for 
the very first activities of the viral genome, even during nonproductive infection. 
1 Introduction 
The observation that membrane insertion of purified viral 
envelope glycoproteins is sufficient to  render target cells sus- 
ceptible to lysis by virus-specific CTL [l] has initiated a series 
[I 41571 
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diate early IL-CTLp: Interleukin-receptive CTL precursors 
LYDIEA: Lymphocyte-detected I.E. antigen(s) MCMV: Murine cy- 
tomegalovirus MEF: Mouse embryo fibroblast(s) PFU: Plaque- 
forming units p.i.: Post infection LN: Lymph node(s) 
00 14-298O/84/0101-00S6$02.50/O 
of reports on the capacity of CTL to discriminate between cells 
infected with serologically related or  unrelated viruses (for 
review see [2]). In the majority of systems studied, it appears 
that the CTL response is less specific than the antibody 
response. 
Concerning a physiological role of CTL in the defense against 
a particular host-specific pathogenic virus, the relevance of 
this “type specificity” is limited if virus strains, which d o  not 
infect the same host naturally, are compared. A more promis- 
ing approach might be  to investigate whether CTL can dis- 
criminate between different antigens specified by the same 
virus and expressed at different stages of the viral replication 
cycle. Herpes virus infections allow a dissection into distinct 
stages and thus can serve as model systems to  test the “replica- 
tion stage specificity” of CTL. Productive infection with 
murine cytomegalovirus (MCMV) is analogous to  that 
described for herpes simplex viruses [3, 41 and leads to  a coor- 
dinately regulated synthesis of viral proteins which can be  
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arranged in at least three groups, denoted alpha (immediate 
early, I.E.), beta (early) and gamma (late). I.E. proteins are 
defined operationally as the first viral proteins translated in 
the presence of actinomycin D (Act.D) after removal of the 
protein synthesis inhibitor cycloheximide (CH). Under these 
experimental conditions the synthesis of early and late pro- 
teins is effectively prevented and thus also the appearance of 
the major viral structural proteins. 
In a preceding report, we have analyzed the events in a drain- 
ing lymph node (LN) during acute MCMV infection and have 
introduced interleukin-receptive CTL precursors (IL-CTLp) 
as representatives of the in vivo-active fraction of the specific- 
ity repertoire [5]. Since these cells are not influenced by the 
selective effects of antigen stimulation in vitro, they can be 
used as a probe to define the identity of those antigens which 
give rise to an antiviral CTL response. In the present report, 
we demonstrate that functionally defined IL-CTLp comprise 
at least two distinct specificity classes. One population of IL- 
CTLp-derived CTL exerts lytic activity towards cells carrying 
viral structural proteins. A second population detects anti- 
gen(s) whose occurrence is correlated with the expression of 
I.E. proteins. This type of antigen(s) is so far only defined by 
lymphocyte recognition and is therefore designated lympho- 
cyte-detected immediate early antigen (LYDIEA). 
vals of 2 weeks. The serum taken 14 days after the last boost 
served as immune serum. 
2.4 Immunoprecipitation analysis 
Biosynthetic labeling of infected MEF was performed after 
withdrawal of CH in methionine-free minimum essential 
medium containing 5% fetal calf serum and 1.25 mCi = 
46.25 MBq/ml [35S]methionine (Amersham, Braunschweig, 
FRG) and 5 pg/ml Act.D for 4 h. Thereafter, the cells were 
lysed by sonication in extraction buffer (10 mM Tris-HC1, 
pH 7.5 containing 150 mM NaCI, 1% sodium deoxycholate, 
1% Nonidet-P40, 0.1% sodium dodecyl sulfate (SDS), 2 mM 
L-methionine, 1 mg/ml ovalbumin and 1 mM phenylmethylsul- 
fonyl fluoride) and the lysates were centrifuged at 40 000 rpm 
(60 min, 4°C) in a Beckman 50 Ti rotor. Supernatant aliquots 
of 1 x lo6 cpm were incubated (60 rnin at 20°C and then 
60 min on ice) with 0.01 ml antiserum or normal mouse 
serum, and the immune complexes were precipitated by the 
addition of 50 p1 Staphylococcus aureus (Pansorbin, Cal- 
biochem, Giessen, FRG). The precipitates were washed and 
then solubilized in sample buffer (62.5 mM Tris-HCI, pH 6.8, 
3% SDS, 10% sucrose, 5% 2-mercaptoethanol, 0.01% 
bromophenol blue) at 95°C for 5 rnin and analyzed in 10% 
SDS polyacrylamide slab gels [8]. Gels were processed for 
fluorography with En3Hance (New England Nuclear, Boston, 
MA) and bands were visualized with Kodak x-Omat R films. 
2 Materials and methods 
3 Results 
2.1 General remarks 
The generation of MCMV-specific CTL, virus preparation, 
cytolytic assay and statistical calculations have been described 
in a preceding report [5]. Female BAJlBlc (H-2d) mice were 
used as responders. 
2.2 Preparation of I.E. target cells 
Secondary passage mouse embryo fibroblasts (MEF) were 
infected as preconfluent monolayers under the influence of a 
centrifugal field (800 x g for 30 min). The centrifugation step 
leads to an enhancement of infectivity [6, 71 and the resulting 
multiplicity of infection is about 2WO-fold the original dose of 
infection. Because of the uncertainty in estimating the factor 
of enhancement, the dose of infection (plaque-forming units, 
PFU/cell) as determined in a conventional plaque titration 
assay is given in the figures. Infection and 3 h of cultivation 
were carried out in presence of CH (50 pgiml; Sigma, Taufkir- 
chen, FRG) to prevent protein synthesis. Thereafter, CH was 
washed out quantitatively and the monolayer was cultured for 
further 2 h in the presence of Act.D (5 pg/ml; Sigma). Finally 
the cells were suspended, labeled with jlCr and used as targets 
in the cytolytic assay. All these steps were performed under 
Act.D to prevent transcription. UV inactivation of virus for 
preparation of structural antigen target was performed with an 
UV illuminator at 254 nm for 5 rnin (RU-VE chroma 41, Vet- 
ter, Wiesloch, FRG). 
2.3 Preparation of MCMV-specific antiserum 
Female BALBic mice at 4-6 weeks of age were infected 3 
times i.p. with lo5 PFU of partially purified MCMV, at inter- 
3.1 Detection of newly synthesized antigens is infection-dose 
dependent 
To define the virus-encoded or virus-induced membrane anti- 
gens, which are synthesized in the course of the viral replica- 
tion cycle, it is mandatory to determine a possible contribution 
I ' 001 005 01 0 2  0 4  
Dose of infection 
Figure 1. Dose dependence of target formation. Day 8 immune lym- 
phocytes (BALBlc, lo5 PFU MCMV footpad, popliteal LN) were 
plated at a density of lo5 cells/microwell. CTL obtained after 6 days of 
IL-mediated (20%, viv) expansion in the absence of antigen were 
tested on syngeneic MEF, which were either infected and incubated 
for 20 h with various doses of MCMV (0-0) or in parallel mock- 
infected with UV-inactivated virions ( 6 0 ) .  Infection was per- 
formed under centrifugal enhancement conditions (800 X g, 30 min) to 
synchronize the viral replication. The dose of infection is given in PFUl 
cell. The median values (n=24)  of lytic activity are depicted. The 
dashed line indicates the detection level belonging to the optimum 
condition (arrow). 
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of those viral structural proteins to target cell formation which 
could be integrated into the cell membrane by fusion during 
the initial steps of infection. The data shown in Fig. 1 demon- 
strate that lytic activity towards cells loaded with input anti- 
gens increased with increasing doses of UV-inactivated vi- 
rions. 
If infectious virus was used and viral replication was allowed to 
proceed for 20 h, ‘‘late’’ conditions were obtained character- 
ized by production of viral DNA and structural protein synthe- 
sis. This way of producing target cell formation was most effec- 
tive and generated optimal assay responses (arrow in Fig. 1) at 
a relatively low dose of infection. At higher doses, the suscep- 
tibility of late targets to CTL-mediated lysis decreased for 
unknown reasons, until finally, the influence of newly syn- 
thesized antigens and input antigens could no longer be distin- 
guished. In repeated experiments the optimum conditions 
varied to some extent depending on the quality of the indi- 
vidual MEF batches used for target cell preparation. For this 
reason it was necessary to control for input antigens in each 
experiment. 
3.2 CTL detect an antigen in parallel to the expression of viral 
I.E. proteins 
Having established the conditions for detecting newly syn- 
thesized antigens, the identity of these antigens and the tem- 
poral pattern of expression could be analyzed. The sequence 
A-D in Fig. 2 illustrates the kinetics of target cell formation 
during productive infection. In this case antigens were first 
detectable by CTL under “early” conditions at 12 h post infec- 
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Figure 2. Kinetics of target formation and enhancement of LYDIEA 
expression by treatment with metabolic inhibitors. MCMV-specific 
CTL were generated as outlined in the legend to Fig. 1 and tested on 
the different target cells indicated. The dose of infection was 0.05 
PFUkarget cell throughout. The rationale for the various inhibitor 
combinations is given in Sect. 3.2. The treatment with metabolic 
inhibitors can be dissected into 2 steps. The first step includes infection 
and the first 3 h of cultivation. The second step lasts until the end of 
the assay period. Under “early” conditions (C) the viral replication in 
target cells did not exceed 12 h, including the assay period, whereas 
target cells expressing late antigens (D) were infected at least 20 h 
before entering the lytic assay. The dashed horizontal bars indicate the 
99% tolerance limits of the low control normal distributions (n = 24) 
and the solid horizontal bars mark the median values of the experi- 
mental data. (n  = 24). 
16 h p.i. (A. Ebeling, unpublished observations). The highest 
lytic activity was measured on ‘‘late’’ targets at 20 h p i .  (D). If 
the ongoing of infection was blocked by Act.D as early as 3 h 
p.i., antigens were not detectable by CTL (B). This failure 
could reflect either an insufficient expression of antigens on 
these cells or a lack of CTL specific for the antigens expressed. 
To decide between these alternatives a special experimental 
device was applied: if protein synthesis is inhibited by CH 
during infection and for several hours thereafter, only a 
limited number of viral genes can be transcribed by the cellular 
RNA polymerase I1 [9]. These genes, the corresponding trans- 
cripts and their translation products have been designated 
“I.E.” [4]. In the normal course of infection, the synthesis of 
I.E. proteins is regulated and only transient. Cessation of this 
regulation as a consequence of CH treatment causes an 
accumulation of I.E. messenger RNA. Removal of CH and 
addition of the transcription inhibitor Act.D then allows 
enhanced synthesis of I.E. proteins and simultaneously pre- 
vents the appearance of early and late transcripts [4]. 
It is noteworthy that this enhancement effect was not only 
demonstrable on the level of the I.E. proteins (compare lanes 
E and F, Fig. 4) but also on the level of the CTL-target cell 
interaction (compare panels B and F, Fig. 2). 
In conclusion, this finding excludes the second alternative and 
indicates that I.E. antigens render target cells susceptible to 
lysis, provided they are expressed in sufficient amounts (F). 
As outlined in Sect. 3.1, it is mandatory to control for input 
antigens. In the present experiment only newly synthesized 
antigens were detected, since lysis was not observed on target 
cells mock-infected with UV-inactivated virions (E) or when 
after infection with the same dose of virus transcription was 
blocked by Act.D throughout the target formation and assay 
period (A). The data of the experiment shown in Fig. 3 sup- 
port and extend these results under modified conditions. As a 
consequence of the increased dose of infection, input antigens 
were now detected. The level of lytic activity was comparable 
irrespective of whether the target cells were prepared with 
UV-inactivated virions (B) or whether transcription (C) or 
translation (D) were blocked during infection. These findings 
confirm that target formation is possible without de now syn- 
thesis of proteins, but also imply that the expression of I.E. 
antigens [compare (A) to (B-D)] indeed requires infectious 
virus [compare (A, B)], transcription [compare (A, C)] and 
translation [compare (A, D)]. The presence of CH during the 
assay period after completed antigen synthesis did not cause 
significant inhibition of target cell lysis [compare (E, F)]. 
The synthesis of I.E. proteins during the period of target for- 
mation was studied in parallel to the cytolytic tests to control 
the differences between the target cell preparations (Fig. 4). 
In contrast to infection with herpes simplex viruses [4] cellular 
protein synthesis is not switched off during infection with 
MCMV [lo]. Immunoprecipitation was therefore used to 
detect virus-encoded or virus-induced proteins in infected cells 
(ICP). Lanes A-C demonstrate the influence of the infection 
dose on the rate of I.E. protein synthesis. Three predominant 
I.E. polypeptides were precipitated (manuscript in prepara- 
tion). Lanes D-F document the CH-mediated enhancement of 
the amount of I.E. protein. After mock-infection with UV- 
inactivated virions ICP were not detectable (compare lanes D 
and F), indicating that the inactivation was effective. This once 
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Figure 3. LYDIEA expression requires infectious virus, transcription 
and translation. BALBic MEF were infected with 0.2 PFU MCMVicell 
and different combinations of inhibitors were applied to allow or pre- 
vent I.E. antigen expression (A-D). Late antigen expression (E-F) 
was obtained by infection with 0.05 PFUlcell followed by 20 h of viral 
replication. Target cells F were further incubated in the presence of 
CH identical to the treatment of target cells D. 
again supports the conclusion that the lytic activity observed in 
panel B of Fig. 3 was not directed towards de novo synthesized 
ICP. 
3.3 I.E. antigens and viral structural antigens are recognized 
by different populations of CTL 
So far the experiments have established that a LYDIEA exists 
and can be demonstrated as a separate entity by the use of an 
appropriate target cell preparation, which lacks detectable 
amounts of viral structural antigens [compare (E) and (F), 
Fig. 21. This by itself does not yet exclude the possibility that 
LYDIEA is part of the virion and accounts for the lytic activity 
observed on target cells prepared with inactivated virus. To 
test this possibility individual microcultures, set up with 
MCMV-primed LN lymphocytes, were split into four identical 
fractions after a 6-day antigen-free expansion period and 
assayed twice on I.E. target cells and twice on target cells 
carrying viral structural antigens. As evaluated by Spearman 
rank correlation analysis (Table 1) the lytic activities on the 
two types of target cells were independently distributed and 
thus the targets under test evidently did not share antigens 
relevant for recognition by CTL. These observations allow the 
conclusion that, in response to infection with a particular 
virus, distinct populations of CTL arise which recognize differ- 
ent antigens in a specific way. Phenotype analysis revealed 
that both populations can be characterized as Thy-l', Lyt-2+ 
lymphocytes (data not shown). 
3.4 During infection LYDIEA-specific memory CTL are 
induced 
Lymphocytes from different somatic or visceral lymph nodes 
of 16-month-old mice infected neonatally with MCMV or  of 
age-matched noninfected controls were subjected to  IL-medi- 
Figure 4 .  Rate of protein synthesis in MCMV-infected MEF under 
different immediate early conditions. I.E. protein synthesis in the indi- 
cated target cell modifications was analyzed by immunoprecipitation. 
The first lane in each triplicate group represents the cell lysate with all 
polypeptides synthesized immediately after removal of CH. The sec- 
ond lane shows those polypeptides which could be precipitated with 
BALBlc MCMV-specific immune serum and as a specificity control 
the third lane documents the precipitation with autologous preimmune 
serum. 
Table 1. LYDIEA and viral structural antigens are recognized by 
separate populations of CTL") 
Target comparison R, P Cor r r: I a t io n 
hypo[ hcsis 
I.E. 1 - I . E . 1  0.671 O.OOO6 Acceptcd 
S I  -s2 0.650 0.0000 Acccptrd 
I .E.2 - S 2  -0.129 0.'670 Ilciected 
I .E . l  - S 2  -0. I53 0.1317 Kcjcctcd 
I .E .1  - S 1  0.072 0.3032 Kcjcctcil 
I.E. 1 - S 1  -0.073 0 3037 lic]cctcd 
Replicate cultures (n = 24) were set up with lo5 lymphocytes at 
day 8 after priming with lo5 PFU MCMV. After a &day in v i m  
expansion period the individual microcultures were split 4-fold and 
tested for lytic activity twice (groups I.E. 1 and I.E.2) on 1.E.- 
MEF (0.05 PFUlcell, CH-Act.D) and twice (groups S 1 and S 2) on 
S-MEF loaded with structural antigens (4 PFU MCMV, UV-inac- 
tivatedicell). The individual cultures were ranked according to 
their lytic activity and the Spearman rank correlation coefficient 
(RJ was calculated [ l l ] .  For R, x (n- 1)05 the attached probability 
values p were taken from tables of the standard normal probability 
function [12]. The correlation hypothesis was accepted for positive 
R, and p < 0.05 (one-tailed test). 
ated expansion in presence or absence of viral antigen 
(Table 2). Results show that lymphocytes from normal mice 
cannot be activated to  lyse cells expressing LYDIEA or late 
viral antigens and that generation of cytolytic effector cells in 
vitvo requires specific memory and antigen, but not interleukin 
only. This fact documents the absence of IL-CTLp in these LN 
at  that stage of infection and also excludes that natural killer 
(NK) cells which could perhaps lyse 1.E.-infected cells in a 
nonantigen-specific manner are generated by IL in vitro. 
Depending on the LN they were derived from, the restimu- 
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Table 2. Detection of memory cells specific for LYDIEA or late antigen in latently 
infected mice”) 
MCMV proteins Mcscnteric LN Axillary LN 
expressed by 
target cells Expansion Restirnulation Expansion Restimulation 
Late”’ < DL“ 37.5 (17.L3-67.0)’’J < DL 33.9 (18.546.0) 
I.E. (CH-Act.D) < D L  29.4 (5 .145 .2 )  < D L  11.9 (0.6-25.3) 
Newborn BALB/c mice were infected i.p. with 10’ 
PFU of MCMV. In surviving females, a latent 
infection was established after 6-8 months. After 
16 months mesenteric as well as axillary LN were 
tested for active IL-CTLp by expansion of lo5 
lymphocytes for 6 days in the presence of IL 
alone or for memory CTL by in vitro restimula- 
tion in the presence of IL and, in addition, 
0.2 PFUicell infectious virus as antigen. Lytic ac- 
tivity measured on mock-infected MEF never ex- 
ceeded the detection level (not included in the 
Table). In neither of the protocols could MCMV- 
specific activity be detected when lymphocytes of 
noninfected age-matched control mice were 
tested. 
b) The conditions for target cell formation are given in legend to Fig. 2. 
c) Minimum positive detection level, defined by the 99% tolerance limit of the low control (n = 24) that ranged from 3.9 to 6.2% specific lysis. 
d) Median value (range) % specific lysis determined from n = 24 individual microcultures. 
lated cells showed different ratios of lytic activity towards the 
two types of infected target cells. This finding is indicative for 
a nonrandom distribution of antigen-specific memory T cells in 
different lymphoid organs. 
4 Discussion 
This report is part of a study on the T cell response of mice to 
infection with the MCMV. Three observations have been 
made: first, target cells could be prepared that carried either 
only viral structural proteins or expressed only I.E. proteins. 
An analysis of the CTL response with respect to these target 
cell properties allowed the conclusion that ICP synthesized 
during the I.E. phase of infection were sufficient to render 
cells susceptible to CTL-mediated lysis. This new type of anti- 
gen(s) has been termed LYDIEA. Secondly, CTL recognizing 
LYDIEA and CTL specific for viral structural antigens belong 
to different populations. Thirdly, IL-CTLp with specificity for 
these different antigens coexist in vivo as active cells at the 
peak of the acute immune response. Earlier reports on pox 
viruses [13-171 and rhabdo viruses [18] have already addressed 
the question of whether early virus-induced membrane altera- 
tions can be recognized by CTL. Using virus mutant strains 
[13, 141 or inhibitors of protein synthesis [16-181, it was con- 
cluded that early antigen expression preceding viral genome 
replication and virion assembly is sufficient for target cell for- 
mation. The question, however, of whether recognition of 
different antigens may occur was not approached in these 
studies. Experiments on the immune response to herpes vir- 
uses led to contradictory interpretations, because the contribu- 
tion of input viral structural antigens could not be evaluated 
[19-211. This question can now be answered. Distinct classes 
of antigens, corresponding with the I.E. and the late phase of 
the MCMV replication cycle, can be identified by separate 
populations of CTL that appear to be “replication-stage 
specific”. Thus, CTL can discriminate between different anti- 
gens induced by one virus. This is in remarkable contrast to 
the frequent observation that CTL cannot discriminate even 
between serologically distinguishable substrains of myxo and 
rhabdo viruses [2]. It is possible that antigens specified by 
different virus substrains, but expressed at the same replica- 
tion stage, are antigenically more related than antigens 
specified by one virus but expressed at different replication 
stages. 
An objection to the in vivo relevance of LYDIEA expression 
could be that significant lysis of cells was only obtained after 
enhancement of I.E. protein synthesis which, under permis- 
sive conditions in vitro, is only low and transient [ 3 ] .  The fact, 
however, that the IL-CTLp which recognize LYDIEA repre- 
sent in vivo active cells not depending on further in vitro 
restimulation and selection by antigen provides evidence that 
LYDIEA expression in vivo is sufficient to induce a clearly 
demonstrable acute response. In addition, specific memory 
CTL for LYDIEA were generated. This indicates either that 
I.E. ICP are highly immunogenic or, more likely, that expres- 
sion of I.E. antigens in vivo is more abundant than expected 
from studying productive infections in vitro. These alternatives 
are presently under investigation. If the latter is correct, IL- 
CTLp may serve as indicator cells for the intensity of viral 
antigen expression in vivo. The antigen LYDIEA is character- 
ized as an ICP synthesized under I.E. conditions and detected 
by lymphocytes. Thus far there is no evidence for an identity 
with any of the I.E. proteins detected by immunoprecipitation 
and there is also no proof that LYDIEA is encoded by the 
viral genome. The situation is reminiscent of the lymphocyte- 
detected membrane antigen (LYDMA) which is seen by T 
cells on Epstein-Barr virus-transformed B cells, but could not 
be identified as a viral product ([22], reviewed in [23]). 
The existence of CTL clones selectively recognizing LYDIEA 
was so far only shown on the population level. The prepara- 
tion of LYDIEA-specific CTL clones would give additional 
proof for these findings, but selection of such clones by limit- 
ing dilution is difficult considering the multitude of MCMV 
virus structural proteins [24] and the paucity of I.E. proteins 
(Fig. 4). Antigen-specific selection was so far not possible due 
to the toxicity of 1.E.-infected inhibitor-treated cells. To 
express selectively I.E. proteins in mammalian cells the 
MCMV genome was cloned [25] and the genomic regions cod- 
ing for I.E. RNA were mapped (G. Keil et al., submitted for 
publication). Presently, appropriate subclones to be inserted 
into a shuttle vector [26] are under construction. 
IL-CTLp appear to be useful for analyzing the antigen 
specificity of the antiviral CTL response. Furthermore, if they 
exist beyond the acute infection, the LYDIEA-specific sub- 
population can serve as an indicator for persistent or recurrent 
activity of the MCMV genome. This activity might even be 
detected under conditions where the viral replication cycle 
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does not proceed to the production of viral progeny and thus 
IL-CTLp may provide a new tool to study herpes virus latency. 
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Three subsets of chicken peripheral T cells (T1, T2 and T3) have been identified in 
peripheral blood of adult chickens on the basis of fluorescence intensity after staining 
with certain xenogeneic anti-thymus cell sera (from turkeys and rabbits). They differ- 
entiate between 3-10 weeks of age in parallel with development of responsiveness to 
the mitogens concanavalin A (Con A), phytohemagglutinin (PHA) and pokeweed 
mitogen (PWM). Functional tests on the T subsets, sorted with a fluorescence-acti- 
vated cell sorter, have shown that T2,3 cells respond to Con A ,  PHA and PWM and 
are capable of eliciting a graft-vs.-host reaction (GvHR). In contrast, although T1 
cells respond to Con A, they respond poorly to PHA and not at all to PWM or in 
GvHR. There was some indication of cooperation between T1 and T2,3 cells for the 
PHA response. Parallels between these chicken subsets and helper and suppressor/ 
cytotoxic subsets in mammalian systems are discussed. 
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Abbreviations: ABS: Anti-bursa cell serum ATS: Anti-thymus cell 
serum Con A: Concanavalin A FACS: Fluorescence-activated cell 
sorter FITC: Fluorescein isothiocyanate GvHR: Graft-vs.-host 
reaction LAF: Lymphocyte-activating factor mAb: Monoclonal 
antibody(ies) PBL: Peripheral blood leukocytes PBS: Phosphate- 
buffered saline PHA: Phytohemagglutinin PWM: Pokeweed 
mitogen TRITC: Tetramethylrhodamine isothiocyanate 
1 Introduction 
The chicken immune system has been much less extensively 
characterized than that of the mouse or man, but several lines 
of evidence have indicated that immunoregulatory circuits 
similar to those found in mammalian systems also exist in this 
species. Amplifier and suppressor functions have been 
described in several different test systems [l-131 and recently 
the production of chicken interleukins 1 and 2 has been 
described 114, 151. 
For formal characterization of T helper and suppressor/ 
cytotoxic subsets and study of their interactions, in a similar 
manner to that originally described in the mouse system 
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